Zobrazeno 1 - 10
of 17 030
pro vyhledávání: '"Antibody response"'
Autor:
Wathusiri Khongsiri, Prapassorn Poolchanuan, Adul Dulsuk, Narin Thippornchai, Rungnapa Phunpang, Chakkaphan Runcharoen, Thitiya Boonprakob, Onura Hemtong, Suchada Chowplijit, Vachara Chuapaknam, Tanaya Siripoon, Watcharapong Piyaphanee, Viravarn Luvira, Chawarat Rotejanaprasert, Pornsawan Leaungwutiwong, Wasun Chantratita, Narisara Chantratita, Nathamon Kosoltanapiwat
Publikováno v:
BMC Infectious Diseases, Vol 24, Iss 1, Pp 1-18 (2024)
Abstract Background Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which causes coronavirus disease 2019 (COVID-19), led to a global pandemic from 2020. In Thailand, five waves of outbreaks were recorded, with the fourth and fifth wave
Externí odkaz:
https://doaj.org/article/eaf27981cafb45dcb2b5a46a9427cb04
Long-term antibody response after the third dose of inactivated SARS-CoV-2 vaccine in MASLD patients
Autor:
Jin Cui, Lianbang Wang, Armin Ghavamian, Xuemei Li, Gongzheng Wang, Tao Wang, Min Huang, Qi Ru, Xinya Zhao
Publikováno v:
BMC Gastroenterology, Vol 24, Iss 1, Pp 1-10 (2024)
Abstract Background Metabolic dysfunction-associated steatotic liver disease (MASLD) patients are at an elevated risk of developing severe coronavirus disease 2019 (COVID-19). The objective of this study was to assess antibody responses and safety pr
Externí odkaz:
https://doaj.org/article/24bd28fc74d44c119e37638126d10a0b
Autor:
Nehlin Tomalika, Md Faizul Ahasan, Smita Debsarma, Sadya Afroz, Naima Ahmed, Md Mohiuddin Tagar, Rishad Mehzabeen, Sraboni Mazumder, Supti Prova Saha, Rehana Khatun, Fahmida Rahman, Md. Shariful Alam Jilani, Nazma Haque, Masuda Mohsena
Publikováno v:
IMC Journal of Medical Science, Vol 18, Iss 2, Pp 1-8 (2024)
Background and objectives: COVID-19 vaccination program has become a global priority to combat the worldwide pandemic. Studies claimed that severity and case fatality could be minimized by vaccination. The durability of antibodies developed after vac
Externí odkaz:
https://doaj.org/article/23425fec3d9c4cec9c8b37e82ade006d
Autor:
Qiuying Zhang, Lirui Jiao, Qiushi Chen, Caroline A. Bulstra, Pascal Geldsetzer, Tulio de Oliveira, Juntao Yang, Chen Wang, Till Bärnighausen, Simiao Chen
Publikováno v:
Systematic Reviews, Vol 13, Iss 1, Pp 1-14 (2024)
Abstract Background The COVID-19 pandemic has caused a large mortality and morbidity burden globally. For individuals, a strong immune response is the most effective means to block SARS-CoV-2 infection. To inform clinical case management of COVID-19,
Externí odkaz:
https://doaj.org/article/318aa7a314d94972b9304c8f681d47dd
Autor:
Linda Elise Couëssurel Wüsthoff, Fridtjof Lund-Johansen, Kathleen Henriksen, Gull Wildendahl, Jon-Aksel Jacobsen, Leni Gomes, Hina Sarwar Anjum, Regine Barlinn, Anne-Marte Bakken Kran, Ludvig Andre Munthe, John T. Vaage
Publikováno v:
Harm Reduction Journal, Vol 21, Iss 1, Pp 1-14 (2024)
Abstract Background During the initial wave of the COVID-19 pandemic, there was a surprisingly low incidence of SARS-CoV-2 among People Who Use Drugs (PWUD) in Oslo, Norway, despite their heightened vulnerability regarding risk of infection and sever
Externí odkaz:
https://doaj.org/article/a8a79e31feef49c99ffcbd30cd0520f0
Autor:
Rongrong Dai, Weiyu Peng, Nani Xu, Pan Qin, Linling Ding, Qianhui Hua, Jianmin Jiang, Fang He, Hangjie Zhang
Publikováno v:
Frontiers in Immunology, Vol 15 (2024)
BackgroundChina experienced a surge of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Omicron variants after adjusting its zero-coronavirus disease 2019 (COVID-19) policy. Although infections with Omicron variants are generally less sev
Externí odkaz:
https://doaj.org/article/1ba728db5ab54b1699ae672ff1f05dc7
Autor:
Melisa Gualdrón-López, Alberto Ayllon-Hermida, Núria Cortes-Serra, Patricia Resa-Infante, Joan Josep Bech-Serra, Iris Aparici-Herraiz, Marc Nicolau-Fernandez, Itziar Erkizia, Lucia Gutierrez-Chamorro, Silvia Marfil, Edwards Pradenas, Carlos Ávila Nieto, Bernat Cucurull, Sergio Montaner-Tarbés, Magdalena Muelas, Ruth Sotil, Ester Ballana, Victor Urrea, Lorenzo Fraile, Maria Montoya, Julia Vergara, Joaquim Segales, Jorge Carrillo, Nuria Izquierdo-Useros, Julià Blanco, Carmen Fernandez-Becerra, Carolina de La Torre, Maria-Jesus Pinazo, Javier Martinez-Picado, Hernando A. del Portillo
Publikováno v:
Frontiers in Cellular and Infection Microbiology, Vol 14 (2024)
Extracellular vesicles (EVs) released by virus-infected cells have the potential to encapsulate viral peptides, a characteristic that could facilitate vaccine development. Furthermore, plasma-derived EVs may elucidate pathological changes occurring i
Externí odkaz:
https://doaj.org/article/2056b388ea7e4fd6b5f14e14cc08dc15
Autor:
Hyeon Hwa Kim, Hye Kyung Lee, Lothar Hennighausen, Priscilla A. Furth, Heungsup Sung, Jin Won Huh
Publikováno v:
Vaccine: X, Vol 20, Iss , Pp 100565- (2024)
The widespread administration of an additional dose of the SARS-CoV-2 vaccine has been promoted across adult populations, demonstrating a robust immune response against COVID-19. Longitudinal studies provide crucial data on the durability of immune r
Externí odkaz:
https://doaj.org/article/176f010e6b804221b7174459c8b0aafd
Autor:
Xue-Dong Song, Guo-Jian Yang, Chao Shi, Xiao-Lin Jiang, Xue-Jun Wang, Yu-Wei Zhang, Jie Wu, Lian-Xiang Zhao, Ming-Ming Wang, Rui-Rui Chen, Xue-Juan He, Er-Hei Dai, Yuan Shen, Hui-Xia Gao, Gang Dong, Mai-Juan Ma
Publikováno v:
International Journal of Infectious Diseases, Vol 147, Iss , Pp 107198- (2024)
Objective: To investigate the effects of repeated vaccination with ancestral SARS-CoV-2 (Wuhan-hu-1)-based inactivated, recombinant protein subunit or vector-based vaccines on the neutralizing antibody response to Omicron subvariants. Methods: Indivi
Externí odkaz:
https://doaj.org/article/7934082d5ef04a7391d7f932d963b283